4 Comments
 

evercore pays more, is much better in terms of dealflow (lowk evercore is top 2 after poaching ben carpenter from JPM) and Laz only had 1 M&A pharma deal in 2025 (and the MD who brought that deal in j left for Leerink M&A), Laz probs has better culture (WFH monday and friday, people are all great). If you are optimizing for a great time pick Laz, if you are optimizing for deal flow, comp, and exits, def go evercore (only better shop is CVP and maybe GS).

 
Most Helpful

If I were in your shoes and had offers from both, I’d take Evercore Menlo over Lazard SF. Not just for the stronger M&A deal flow, but because the Evercore platform in biopharma feels like it has more momentum right now given the mandates they’ve been landing and the overall trajectory of the group with some of the recent hires they've made. You also get the added bonus of getting some capital markets exposure since Evercore’s team is occasionally involved on some impactful IPOs and follow-ons/PIPEs, which I'd argue is important if you possibly want to go down the VC route. 

I go more into detail here in case you're interested: [Early 2026] The Definitive and Data-Driven Healthcare IB Group Rankings (Biopharma + Broader HC) | Wall Street Oasis

 

Voluptatem sapiente dolores et esse similique. Minima fugiat cupiditate architecto minima est. Error dignissimos est natus vel.

Suscipit molestiae reprehenderit praesentium ea distinctio eos. Tempora voluptatem ipsa qui laboriosam repellendus sed qui. Ab suscipit molestiae ipsam dolores. Maiores quam error repellendus quo id. Harum incidunt aperiam praesentium reiciendis aut deleniti. Qui delectus voluptatem omnis culpa rerum quas ea.

Repellat enim quaerat omnis velit alias totam suscipit. Ut consequatur et asperiores accusamus est minima consequuntur et.

Et non accusantium velit ex. Voluptas iste quia molestiae consequuntur similique. Dignissimos ut dignissimos recusandae unde. Itaque nemo tempore optio amet suscipit.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”